<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00194428</url>
  </required_header>
  <id_info>
    <org_study_id>802132</org_study_id>
    <nct_id>NCT00194428</nct_id>
  </id_info>
  <brief_title>Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons</brief_title>
  <official_title>Weight and Metabolic Effects of an Almond Enriched Hypocaloric, Low Fat Diet on Overweight and Obese Persons</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Temple University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Almond Board of California</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Temple University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this trial is to study the safety, tolerability and efficacy of an almond
      enriched hypocaloric diet on weight loss and weight maintenance, as well as on established
      and emerging cardiovascular risk factors in approximately 112 overweight and obese persons.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A randomized, non-blinded, controlled clinical trial using a parallel design of a
      hypocaloric, low fat (&lt;30% energy from fat) diet with or without 2 oz of almonds over 18
      months. Interim analyses will be conducted at 3, 6, 9 and 12 months. The study will be
      divided into 3 phases. Phase 1 (months 0-6) will be an active, intensive weight loss phase.
      During phase 1, all subjects will meet once a week in the evening for 1.5 hours. Phase 2
      (months 6-12) will be a less intensive weight loss phase. During phase 2 groups will meet
      every other week in the evening for 1.5 hours. The last phase will be the weight maintenance
      phase or phase 3 (months 12-18).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2005</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">October 2007</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To evaluate the effects of an almond-enriched (2 oz/day) hypocaloric, low-fat diet on body weight and body composition in overweight and obese persons</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To evaluate the effects of the almond enriched diet on established and emerging surrogate markers of coronoary artery disease (CAD) risk</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">123</enrollment>
  <condition>Obesity</condition>
  <condition>Metabolic Syndrome X</condition>
  <condition>Hyperlipidemia</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Almond enriched diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Low-fat diet</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Almond enriched diet</intervention_name>
    <description>Subjects will consume 2 oz. of almond per day in addition to a low-fat diet</description>
    <arm_group_label>1</arm_group_label>
    <other_name>AED</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Low fat caloric diet</intervention_name>
    <description>Low fat caloric diet</description>
    <arm_group_label>2</arm_group_label>
    <other_name>LFD</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Body mass index (BMI) &gt; 27 but &lt;40

          -  18-75 years of age

          -  Men and non-pregnant or lactating women

          -  Subjects must be willing to comply with all study-related procedures

        Exclusion Criteria:

          -  Uncontrolled hypertension

          -  Diabetes or use of anti-hyperglycemic medication

          -  Dyslipidemia requiring prescription drug therapy as defined by NCEP ATPIII guidelines
             at screening

          -  Known allergy or sensitivity to nuts

          -  Known atherosclerotic cardiovascular disease

          -  History of congestive heart failure

          -  History of a non-skin malignancy within the previous 5 years

          -  Any major active rheumatologic, pulmonary, hepatic, renal, dermatologic disease or
             inflammatory condition

          -  History of being HIV positive

          -  History of alcohol or drug abuse

          -  Weight-loss inducing medications or dietary supplements within 3 months prior to
             enrollment.

          -  Weight loss &gt; 5 kg during the last 6 months

          -  Participation in an investigational drug study within 6 weeks prior to screening

          -  Serious or unstable medical or psychological conditions that, in the opinion of the
             investigator, would compromise the subject's safety or successful participation in the
             study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gary D Foster, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Temple University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Temple University</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19140</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.almondsarein.com</url>
  </link>
  <link>
    <url>http://www.almondboard.com</url>
  </link>
  <reference>
    <citation>Jenkins DJ, Kendall CW, Marchie A, Faulkner D, Vidgen E, Lapsley KG, Trautwein EA, Parker TL, Josse RG, Leiter LA, Connelly PW. The effect of combining plant sterols, soy protein, viscous fibers, and almonds in treating hypercholesterolemia. Metabolism. 2003 Nov;52(11):1478-83.</citation>
    <PMID>14624410</PMID>
  </reference>
  <reference>
    <citation>Wien MA, Sabaté JM, Iklé DN, Cole SE, Kandeel FR. Almonds vs complex carbohydrates in a weight reduction program. Int J Obes Relat Metab Disord. 2003 Nov;27(11):1365-72. Erratum in: Int J Obes Relat Metab Disord. 2004 Mar;28(3):459.</citation>
    <PMID>14574348</PMID>
  </reference>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2005</study_first_submitted>
  <study_first_submitted_qc>September 14, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 19, 2005</study_first_posted>
  <last_update_submitted>March 26, 2013</last_update_submitted>
  <last_update_submitted_qc>March 26, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 28, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Obesity,</keyword>
  <keyword>Metabolic Syndrome,</keyword>
  <keyword>BMI</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Overweight</mesh_term>
    <mesh_term>Metabolic Syndrome X</mesh_term>
    <mesh_term>Hyperlipidemias</mesh_term>
    <mesh_term>Hyperlipoproteinemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

